Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.
3.
5.

[Influencing factors for the curative effects of short-term continuous subcutaneous insulin infusion on newly diagnosed type 2 diabetes].

Li YB, Zhu HL, Yao B, Huang ZM, Ou XZ, Xiao YB, Weng JP.

Zhonghua Yi Xue Za Zhi. 2005 Mar 9;85(9):602-5. Chinese.

PMID:
15949356
6.

Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.

Tîrgovişte CI, Străchinariu R, Farcaşiu E, Milicevic Z, Teodorescu G.

Rom J Intern Med. 2003;41(2):153-62.

PMID:
15526500
7.
8.

Investigation of the insulin dose and characteristics of continuous subcutaneous insulin infusion in Chinese people with type 2 diabetes.

Gao GQ, Dong QY, Li SJ, Zhang YY, Li WX, Du WH, Liang CG, Wang YL.

Diabetes Technol Ther. 2011 Nov;13(11):1135-8. doi: 10.1089/dia.2011.0109. Epub 2011 Sep 15.

PMID:
21919776
9.

Beneficial effects of continuous subcutaneous insulin infusion in older patients with long-standing type 1 diabetes.

Rizvi AA, Petry R, Arnold MB, Chakraborty M.

Endocr Pract. 2001 Sep-Oct;7(5):364-9.

PMID:
11585372
10.
12.
13.

Efficacy and safety of prandial premixed therapy using insulin lispro mix 50/50 3 times daily compared with progressive titration of insulin lispro mix 75/25 or biphasic insulin aspart 70/30 twice daily in patients with type 2 diabetes mellitus: a randomized, 16-week, open-label study.

Farcasiu E, Ivanyi T, Mozejko-Pastewka B, Birkus Z, Csog J, Kowalska I, Coetzer TF, Bulgurlu S, Schinzel B, Kiljanski J.

Clin Ther. 2011 Nov;33(11):1682-93. doi: 10.1016/j.clinthera.2011.10.001. Epub 2011 Oct 27.

PMID:
22036246
14.

Serum leptin concentrations in children with type 1 diabetes mellitus: relationship to body mass index, insulin dose, and glycemic control.

Soliman AT, Omar M, Assem HM, Nasr IS, Rizk MM, El Matary W, El Alaily RK.

Metabolism. 2002 Mar;51(3):292-6.

PMID:
11887162
15.

Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.

Raskin P, Bode BW, Marks JB, Hirsch IB, Weinstein RL, McGill JB, Peterson GE, Mudaliar SR, Reinhardt RR.

Diabetes Care. 2003 Sep;26(9):2598-603.

PMID:
12941725
16.

[Metabolic control in young children with type 1 diabetes treated with continuous subcutaneous insulin infusion (insulin pump)].

Pańkowska E, Lipka M, Wysocka M, Szypowska A, Trippenbach-Dulska H, Czaplińska M, Kołodziejska B.

Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2003;9(1):11-5. Polish.

PMID:
12831632
17.

A randomized prospective study of insulin pump vs. insulin injection therapy in very young children with type 1 diabetes: 12-month glycemic, BMI, and neurocognitive outcomes.

Nabhan ZM, Kreher NC, Greene DM, Eugster EA, Kronenberger W, DiMeglio LA.

Pediatr Diabetes. 2009 May;10(3):202-8. doi: 10.1111/j.1399-5448.2008.00494.x. Epub 2008 Dec 18.

PMID:
19140899
18.

A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes.

Herman WH, Ilag LL, Johnson SL, Martin CL, Sinding J, Al Harthi A, Plunkett CD, LaPorte FB, Burke R, Brown MB, Halter JB, Raskin P.

Diabetes Care. 2005 Jul;28(7):1568-73.

PMID:
15983302
19.
20.

Supplemental Content

Support Center